Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Cohort With Hemopathy in Languedoc-Roussillon (DataDiag2012)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02134574
Recruitment Status : Recruiting
First Posted : May 9, 2014
Last Update Posted : September 7, 2015
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier

Brief Summary:
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.

Condition or disease Intervention/treatment
Hematologic Malignancy Biological: hematologic malignancy

Detailed Description:
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy in LR.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Cohort Study of Clinical and Laboratory Data of Patients With Hemopathy in Languedoc-Roussillon
Study Start Date : February 2014
Estimated Primary Completion Date : June 2033
Estimated Study Completion Date : June 2033

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
hematologic malignancy
hematologic malignancy with a sampling of blood
Biological: hematologic malignancy
hematologic malignancy with a sampling of blood
Other Name: hematologic malignancy with a sampling of blood




Primary Outcome Measures :
  1. Survival with 2 years [ Time Frame: 2 years ]
    Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC_QLQ-C30


Secondary Outcome Measures :
  1. Survival with 5 years [ Time Frame: 5 years ]
    Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC_QLQ-C30

  2. Survival with 10 years [ Time Frame: 10 years ]
    Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC_QLQ-C30


Biospecimen Retention:   Samples With DNA
Blood and marrow


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patient for suspected haematological disease and justifying further exploration
Criteria

Inclusion criteria:

  • Consultant or hospitalized patient for suspected haematological disease and justifying further exploration
  • Having signed an informed consent

Exclusion criteria:

  • Minor or major protected
  • Patients who have received treatment for hematological pathology

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02134574


Contacts
Layout table for location contacts
Contact: Valerie ROUILLE v-rouille@chu-montpellier.fr

Locations
Layout table for location information
France
Hematology department - UHMontpellier Saint éloi Recruiting
Montpellier, France
Contact: Valerie ROUILLE       v-rouille@chu-montpellier.fr   
Principal Investigator: GUILLAUME CARTRON         
Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Layout table for investigator information
Principal Investigator: GUILLAUME CARTRON University Hospital, Montpellier
Layout table for additonal information
Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT02134574    
Other Study ID Numbers: 9011
First Posted: May 9, 2014    Key Record Dates
Last Update Posted: September 7, 2015
Last Verified: September 2015
Keywords provided by University Hospital, Montpellier:
Lymphoma,
leukemia,
multiple myeloma,
hodgkin disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Hematologic Neoplasms
Neoplasms
Neoplasms by Site
Hematologic Diseases